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Introduction
Currently, the number and (worldwide) availability of 
techniques for hemodynamic monitoring in the critically 
ill patient is overwhelming, as nicely summarized else-
where [1–11]. Techniques vary from completely invasive 
to non-invasive, from intermittent to continuous, and 
diﬀ  er in basic principles, methods, parameters, and costs, 
among others. Th   e older a device, the more literature is 
available, but the latter may not always help in choosing 
hemodynamic monitoring tools for depart  ments or for 
individual patients, i.e. patient-tailored monitoring.
Th   is chapter is not intended to compare one technique 
to another, which has been done abundantly in the 
literature, but to provide a conceptual framework to 
guide therapy of individual patients in various hospital 
settings by deﬁ  ning the elements that may help to choose 
among the available techniques, in the absence of a clear 
evidence-based survival beneﬁ   t of any hemodynamic 
monitoring tool [12–16]. First, a brief discussion of what 
is available and of underlying basic principles seems 
warranted, since knowledge of possibilities, limitations 
and pitfalls is required before responsible choices can be 
made. We will not address tools to monitor the 
micro circulation.
What do we have and what can they do?
A physical examination remains the cornerstone of 
assess  ing patients with hemodynamic compromise, even 
though signs and symptoms often poorly predict 
measured hemodynamic variables [13, 17]. Nevertheless, 
clinical signs and symptoms help to clearly deﬁ  ne the 
clinical problem and its diﬀ   erential diagnosis. As an 
adjunct, some type of hemodynamic monitoring is often 
decided upon, depending on the clinical severity of 
disease and the (department of) presentation of the 
patient, among other factors. Table 1 brieﬂ  y summarizes 
the currently available equipment for advanced hemo-
dynamic monitoring, beyond that of mean arterial 
pressure (MAP) and heart rate/rhythm. As indicated, a 
wide variety of hemodynamic parameters can be 
monitored by the diﬀ   erent techniques, in addition to 
cardiac output. Th   e parameters pertain to cardiac ﬁ  lling 
and function and its adequacy related to tissue needs. In 
addition, pulmonary variables pertaining to edema and 
gas exchange can be assessed with some devices.
Th  ere is a large amount of literature concerning the 
comparability of techniques and derived parameters, 
such as (absolute values and changes in) cardiac output 
and preload indicators [4–7, 18, 19]. However, the manner 
in which the comparability (or clinically important 
absence thereof) is judged varies greatly among studies. 
Uniformly accepted criteria to assess the clinical 
relevance of comparability of monitoring techniques and 
parameters are lacking. For instance, comparability of 
techniques for tracking changes and trends in cardiac 
output may be more relevant in clinical practice than the 
degree of agreement of absolute values, provided that 
`low' and `high' values can be separated [19]. Moreover, 
literature on the practical utility of many of these devices 
and parameters is scarce, so that negativism regarding 
their practical value may predominate [16, 20]. Th  ere  is, 
however, some literature to suggest that insertion of a 
pulmonary artery catheter (PAC) and measuring hemo-
dynamic variables may inﬂ  uence the clinical appraisal of 
hemodynamics at the bedside and may help or prompt 
the treating physician to change treatment.
Since its introduction in the 1970s, the PAC has indeed 
become the reference standard for hemodynamic 
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A substantial knowledge database has been built up since 
then, in a variety of institutions, patient populations, and 
circumstances [16]. However, in the absence of any 
rigidly proven survival beneﬁ  t, the catheter has become 
discredited in critical care medicine [12–16]. Th   e lack of 
apparent beneﬁ  t may relate, in part, to adverse eﬀ  ects of 
insertion, improper use, poor interpretation of hemo-
dynamic data, and inadequate treatment decisions based 
on the collected variables, or combinations of these 
factors [20]. Conversely, the value of pulmonary artery 
pressures, pulmonary artery occlusion pressure (PAOP), 
mixed venous oxygen saturation (SvO2), and right heart 
volumes, some of the variables that can be uniquely 
assessed at the bedside of the critically ill patient with 
help of the PAC and right-sided thermodilution, remains 
hotly debated [13–15, 20]. Th  e patient population or 
circumstance that is most likely to beneﬁ  t from pulmo-
nary artery catheterization is, therefore, still being 
actively looked for [13–15, 21, 22].
A second generation hemodynamic monitoring prin-
ciple includes the less invasive transpulmonary (dye) 
thermodilution technique, e.g. PiCCO. Th  is technique 
oﬀ  ers the unique possibility of estimating cardiac preload 
volumes, measurements of which are not confounded by 
mechanical ventilation in contrast to pressure and 
dynamic indices of preload and ﬂ  uid responsiveness, and 
of extravascular lung water as a direct measure of 
pulmonary edema and permeability. Dilutional methods 
to measure cardiac output include the transpulmonary 
lithium and indocyanine green (pulse dye) techniques, 
allowing peripheral injections and peripheral and, for 
pulse dye, non-invasive detection.
Pulse-contour or pulse-power methods, needing rela-
tively frequent recalibration for optimal performance in 
tracking changes in cardiac output, are often incor-
porated in dilutional cardiac output measurement 
devices needing arterial access [5, 18]. Some of these 
methods are truly non-invasive, however. Th  e  algorithms 
used diﬀ  er from one method to the other, some perform 
better than others, and the need for recalibration upon 
changes in time or in vascular tone upon treatment 
continue to limit their independent applicability [5, 18]. 
Calibration can also be performed by ultrasonically 
obtained aortic diameter for the otherwise well perform-
ing Model ﬂ  ow method [23]. Th   e algorithm used in the 
latter method computes the aortic ﬂ  ow waveform from 
pulsating arterial blood pressure by simulating a non-
linear, self-adaptive (three-element Windkessel) model of 
the aortic input impedance. Characteristic impedance 
and compliance of the aorta non-linearly depend on 
arterial pressure, and peripheral resistance adapts to 
changes in blood ﬂ  ow.  Th  e degree of non-linearity 
depends on the subject’s sex, age, height, and weight.
An arterial waveform analysis without external calibra-
tion, the FloTrac/Vigileo system, is supposed to be 
relatively independent of vascular tone [9]. Each arterial 
waveform detected via an arterial catheter is analyzed 
with a frequency of 100  Hz. Th  e arterial waveform is 
analyzed for 8 diﬀ   erent characteristics, including the 
upstroke and downslope of the curve. Each curve is 
analyzed separately and additional curves are analyzed 
and compared with former and subsequent curves. From 
this analysis, which takes 20 seconds, the average curve is 
given, by means of the standard deviation of the given 
characteristics of the curves. From the given stroke 
volume and heart rate, the cardiac output is determined, 
which is updated every 20 seconds. A ﬁ  lter is embedded 
in the computer to adjust for excesses in systolic blood 
pressures and heart rates. Th  e accuracy of this method 
has increased with consecutive software versions.
Doppler ultrasound methods estimate cardiac output 
by measuring aortic blood ﬂ  ow velocity [10, 11, 24, 25] 
and multiplying it by the cross-sectional area of the aorta 
at the insonation point. Th   e probe is introduced orally or 
nasally and placed at the level of the descending aorta. 
Some systems measure the descending aortic diameter; 
others use a monogram to estimate it. Limitations of the 
Table 1. What do we have and what can they do?
Equipment
Central venous catheter (many companies)
Pulmonary artery catheter and modifi  cations (some companies)
PiCCOII (Pulsion)
LiDCOplus (LiDCO)
NICO (Novametrix)
Modelfl  ow pulse contour analysis (BMI-TNO)
Nexfi  n (Bmeye)
Flotrac/Vigileo (Edwards Life Sciences)
Pulse-dye densitometry PDD (Nihon Kohden)
Bioimpedance cardiography (Aesculon, Osypka Medical)
Hemosonic (Arrow)
CardioQ (Deltex Medical)
Ultrasonic cardiac output monitors (Uscom)
Echocardiographs (some companies)
Parameters
Cardiac pressures and volumes
Cardiac output, fl  ow, velocity/time
Dynamic indices
Cardiac anatomy and regional function
Oxygen-related variables
Carbon dioxide-related variables
Vascular diameters
Manufacturers in parentheses.
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optimal angle of insonation, turbulent ﬂ  ow, and changes 
in relative perfusion of upper and lower body parts via 
the aorta. Obviously, echocardiography yields clinically 
useful information on cardiac anatomy and (regional) 
function that is hard to obtain otherwise, in addition to 
non-unique parameters, such as cardiac ﬁ  lling  and 
output [26, 27]. Th  e technique is highly dependent on 
available expertise and commitment.
Factors aff  ecting choices
Tables 2–4 describe the issues that may be relevant for 
decision making, including theoretical considerations, 
the hardware involved, and patient-bound factors. 
Indeed, demands put on technologies may vary according 
to need in diﬀ  erent hospital environments and patient 
populations. We will highlight just some of the considera-
tions mentioned in the Tables. Table 2 essentially notes 
theoretical considerations, suggesting that the ideal 
hemo  dynamic monitoring tool should be simple, safe, 
relatively versatile, uniformly applicable and beneﬁ  cial 
for survival in each patient subjected to that tool, at low 
or at least aﬀ  ordable costs. Obviously, no method yet ﬁ  ts 
this `ideal’ list, and perhaps never will, so some compro-
mise on these issues remains necessary.
Some hemodynamic optimization strategies, such as 
ﬂ   uid management guided by prediction of ﬂ  uid  res-
ponses, early goal-directed therapy, and perioperative 
hemodynamic optimization or ﬂ  uid restriction, may help 
to improve patient outcomes, in terms of reducing 
complications, lengths of stay, and prevention of over-
hydration, for example, even irrespective of vital status 
[1, 16, 25, 28–33]. Devices and parameters to assess ﬂ  uid 
responsiveness include transpulmonary dilution-derived 
cardiac volumes, esophageal Doppler ﬂ  ow  and 
echocardiographic indices, and dynamic indices provided 
by pulse-contour methods [10, 11, 24, 25, 33, 34]. In 
contrast, central venous pressure (CVP) monitoring may 
suﬃ   ce in successful ﬂ  uid restriction policies [32]. Th  e 
well-known outcome (survival) beneﬁ   t of early goal-
directed therapy in septic shock, with treatment guided 
by CVP, central venous oxygen saturation (ScvO2) and 
MAP, has been conﬁ  rmed by others, since the landmark 
paper by Rivers et al. [35] and this approach is included 
in current guidelines on the management of septic shock 
[1, 31], even though CVP may poorly predict ﬂ  uid 
responses [36]. Hence, monitoring tools could be judged 
on their ability to provide parameters that help physicians 
to implement the strategies mentioned, even if these are 
slightly diﬀ  erent from those originally used in demon-
strating beneﬁ  t but apply similar physiologic and clinical 
concepts [1, 15, 30, 37–39]. For example, the beneﬁ  t of 
perioperative hemodynamic optimization with help of 
the PAC [28], transpulmonary/lithium dilution [29, 30], 
esophageal Doppler [10, 11, 24, 25], or dynamic indices 
[38] could translate into a beneﬁ   t of optimization of 
central/mixed venous oxygen saturation since all are 
intended to optimize tissue oxygenation [37]. Never  the-
less, not all devices and parameters have been 
successfully evaluated yet in hemodynamic optimization 
strategies and these issues continue to be subject to 
ongoing research and debate [1, 15, 37, 39, 40]. Th  us,  we 
may need to formulate and test hemodynamic monitor-
ing strategies, rather than to evaluate performance and 
eﬃ   cacy of single devices and parameters. Th   e rationale of 
these strategies may be enforced if led by physiological 
and clinical considerations as well as by epidemiological 
and economic issues. Finally, eﬀ   ectiveness could be 
Table 2. Theoretical considerations for choosing among 
hemodynamic monitoring tools
•  Safety and side eff  ects
•  Versatility, number, relevance and utility of parameters
•  Can be utilized by nurses and physicians: Ease of use, user-friendliness, 
  education, learning curve
•  Possibilities for assessing fl  uid responsiveness, goal-directed therapy 
  and other resuscitation strategies of proven outcome benefi  t even if not 
 decreasing  mortality
•  Demonstrated treatment alterations
• Acceptable  cost-eff  ectiveness
Table 3. Hardware considerations for choosing among 
hemodynamic monitoring tools
• Availability
•  Expertise: Personal, colleagues, and in the literature
•  Ease of use and interpretation; operator-dependency
•  Level of integration in monitors
•  Uniformity of applicability
•  Continuous vs intermittent
•  Invasive vs non-invasive
•  Accuracy/reproducibility of parameters
•  Response time to interventions and accurate trending
Table 4. Patient-bound considerations for tailoring 
hemodynamic monitoring
•  Cardiac rhythm, function, and valvular disease
•  Mechanical ventilation: Tidal volume, frequency, positive end-expiratory 
 pressure
•  Type, severity and stage of (anticipated) disease warranting 
  hemodynamic monitoring, such as shock and acute lung injury
•  Type of circulatory support and change contemplated therein: Fluids, 
  drugs, devices for circulatory support
•  Vascular access and other anatomic factors (contraindications)
• Tolerance
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parameters that may go beyond their formally reported 
eﬃ   cacy.
Hardware considerations (Table 3) include the environ-
ment where the hemodynamic monitoring is used. 
Diﬀ   erent departments may have diﬀ  erent  facilities, 
patient populations and staﬃ   ng, and pressures on time 
by emergencies may drive choices for less invasive 
techniques that can be applied immediately by most of 
the available staﬀ  . Non-invasive hemodynamic monitor-
ing devices may also be of help in departments without 
facilities for invasive techniques, such as step-down 
units, long-term facilities, and stroke units. By virtue of 
deﬁ   nition, any device that is able to accurately detect 
rapid changes in cardiac output upon ﬂ  uid  challenge 
would suﬃ   ce in evaluating ﬂ  uid responsiveness and some 
methods may be too slow to fulﬁ  ll this criterion.
General considerations regarding patient-bound factors 
(Table 4) include the notion that the sicker the patient the 
greater the need for accurate hemodynamic parameters 
to be collected to supplement clinical judgment and the 
greater likelihood that invasive, rather than less invasive, 
techniques will meet these needs. In the patient with 
severe septic shock admitted to the intensive care unit 
(ICU) for instance, non-invasive arterial waveform 
analysis-derived cardiac output measurements are less 
useful as they are aﬀ  ected by vascular tone and require 
repeated recalibration, at least in the initial resuscitation 
phase. In patients with or at great risk of pulmonary 
edema, hemodynamic monitoring by transpulmonary 
dilution and measurements of extravascular lung water 
could be chosen to help to prevent harmful overhydration 
and prolonged mechanical ventilation, unless the patient 
will anyway need to be intubated and mechanically 
ventilated. Catheters in the femoral artery are relatively 
contraindicated during/after aortic-bifemoral recon  struc-
tion, and transesophagal echocardiography is not feasible 
during/after esophageal resection. Esophageal disease 
may be a contraindication for the use of esophageal 
Doppler probes, which are also poorly tolerated in awake, 
non-intubated patients [10, 20, 25]. Th  e presence of 
cardiac disease and mechanical ventilation may also 
aﬀ  ect choices. It is likely that a PAC and measurement of 
PAOP is more helpful in guiding (ﬂ  uid) management in 
the presence of systolic/diastolic cardiac dysfunction 
than during hypovolemic shock, for example [21, 34]. In 
severe left-sided valvular disease, right-sided measure-
ments of cardiac output are probably preferable to 
transpulmonary ones, even though the debate on the 
confounding eﬀ  ect of even minimal tricuspid regurgita-
tion on these measurements has not yet ended. In the 
presence of endocarditis, intracardiac catheters may be 
relatively contraindicated. In contrast, a suspected ventri-
cular septal defect may require monitoring with help of a 
PAC, echocardiography, or both. In mechanically venti-
lated patients, ﬁ  lling pressures that are confounded by 
airway pressures may be less useful in predicting and 
guiding ﬂ   uid responses than volumetric preload 
measure  ments [34, 36], whereas the currently proposed 
superiority of dynamic indices [33] can be questioned, as 
they are aﬀ   ected by ventilatory frequency and tidal 
volume. Finally, pulse-contour methods are sensitive to 
arrhythmias, aortic valve regurgitation, intra-aortic 
balloon pumping and peripheral vascular disease.
Conclusions and perspective
Th   is chapter attempts to provide a conceptual framework 
for choosing patient-tailored hemodynamic monitoring 
from available techniques, in an era dominated by lack of 
proven survival beneﬁ  ts for any hemodynamic monitor-
ing device. Decisions for implementing diﬀ  erent hemo-
dynamic monitoring devices may improve when 
systematically considering the relevant issues, according 
to a predeﬁ  ned checklist, for example. Th   is approach may 
help to end debates on the use of hemodynamic monitor-
ing equipment from single perspectives only, but 
obviously choices may diﬀ   er from one hospital, unit, 
patient and physician to another, given the variability in 
facilities, clinical presentations, and expertise. One tool 
may supplement another, so that it is advisable to gain 
expertise in more than one method, particularly in 
training environments. Health technology assessment 
institutions and agencies can be of help in advising on 
these complex issues and emergency and intensive care 
medicine organizations could beneﬁ  t from their expertise 
[1, 12, 13, 25, 41]. Th   e underlying idea, of course, is that 
helping physicians to direct therapy using numbers 
rather than signs and symptoms, and helping the medical 
community by providing clear clinical guidelines on 
hemodynamic monitoring strategies will eﬀ  ectively result 
in health care improvements. Perhaps, we also need a 
new research agenda on these issues.
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